|
|
|
| This article has been cited by | | 1 | Genetics of the patent ductus arteriosus (PDA) and pharmacogenetics of PDA treatment | | | Tamorah R. Lewis,Elaine L. Shelton,Sara L. Van Driest,Prince J. Kannankeril,Jeff Reese | | Seminars in Fetal and Neonatal Medicine.2018;23(4)232 | | [DOI] | | | 2 | Warfarin | | | Tamorah R. Lewis,Elaine L. Shelton,Sara L. Van Driest,Prince J. Kannankeril,Jeff Reese | | Reactions Weekly.2015;1558(1)195 | | [DOI] | | | 3 | Pharmacogenetics of vitamin K antagonists and bleeding risk prediction in atrial fibrillation | | | María José Serna,José Miguel Rivera-Caravaca,Rocío Gonzalez-Conejero,María Asunción Esteve-Pastor,Mariano Valdés,Vicente Vicente,Gregory Y.H. Lip,Vanessa Roldán,Francisco Marín | | European Journal of Clinical Investigation.2018;48(6)195 | | [DOI] | |
|
